Agenda
- Session 5: Choice of two break-out sessions
- Session 5A: Biocides topics overlapping with other legislation
-
Chair:
-
Is my product a cosmetic, biocide, or both ? - assessment criteria for the borderline
-
Does the BPR promote innovations in disinfection?
- Probiotics
- Super-oxidised water
- Re-formulated hydrogen peroxide
- Chemical leasing
-
BPR and other legislative regimes
- The legislators’ original intention
- Legislative overlaps and conflicts
- Classification and labelling
- Treated articles
- Impact for global industries:
- a 'road to nowhere' or
- a 'highway to hell'
-
Q&A
-
Refreshments
-
Moderators' feedback
- Session 6: Sustainability of biocides and circular economy
-
Chair:
-
Efficacy assessment and sustainability
- As little as possible – as much as necessary
- The fear of bacteria and the ”precautionary principle”
- A highly regulated market versus a consumer’s free choice
- The quest for easy
- Efficacy as necessary base for using a biocide
- Beyond efficacy… (Efficacy necessary but not sufficient)
-
New active substance, sustainable uses – the case for chlorine dioxide
- Chlorine dioxide – a sustainable treatment alternative
- Methods of generation – enough to cover everything?
- An alternative delivery system (ex situ)
- Case examples of sustainable uses
-
The contribution of biocides to sustainable economies
- Benefits of biocides within the regulatory framework
- Case examples of the value of biocides to sustainable economies
- The past, the present and the future –a compelling need for change
Ian Watt
Regulatory Sciences and Product Sustainability, Microbial Control, DuPont Specialty Products Division, UK -
Silver leaching: A report on silver in sportswear
-
Q&A
-
Lunch
- Session 6: Sustainability of biocides and circular economy continued
-
Substitution of chemicals of concern – Promoting innovation by facilitating partnerships
- The Europe Enterprise Network and the Partnership Opportunities Database (what they are, how they work)
- Project’s objectives and what we have done
- Market segments (companies’ needs and attitudes towards substitution, how to further support them and how to reach them)
- Lessons from the biocidal product market
-
Not only biocides: a contribution from microbial-based systems for infection and antimicrobial resistance (AMR) control
- Healthcare-associated infections are a global concern: persistent microbial contamination and AMR of pathogens are major causes
- Microbial-based sanitation approaches can be very efficient in stably abating pathogens and their AMR
- Results of our studies (published research)
- Further innovations and future perspectives
Elisabetta Caselli
Associate Professor of Clinical Microbiology, Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Italy -
Panel with Q&A
- What does sustainable use of biocides entail?
- What is the role of biocides in a circular economy?
- How to define a workable regulatory framework for substitution of substances?
-
Refreshments
- Session 7: Testing and modelling
-
Guidance development overview from German efficacy expert
-
Impact of substance ID on read-across, data sharing and testing, and its strategic implication for registrations
- Background to substance identity (focus on UVCB substances)
- Interplay between REACH, BPR and PPP Regulations – how to ensure consistency of approach
- How should UVCB substances be named and identified under the BPR and who should be involved
- Redefinition of active substances
- The balance between unnecessary animal testing and correct hazard assessment
- source versus composition-based naming
- narrow substance definition versus broad substance definition
- The grey area of when two compositions are the same or not – substance sameness
- What to do when substance id/substance definition causes practical problems for data sharing under biocides
-
Recent developments and technical issues with the testing of in situ generated active substances and products
- Background around in-situ actives and the BPR
- Overview of current guidance on data requirements
- Technical issues faced by in-situ actives
-
Q&A session
-
Close of conference
